Papua New Guinea vs Sao Tome and Principe: Previously treated cases tested for RR-/MDR-TB
Papua New Guinea
100.0%
in 2024
Sao Tome and Principe
100.0%
in 2024
Papua New Guinea rank
1st
Sao Tome and Principe rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Papua New Guinea
- Sao Tome and Principe
How they compare
Papua New Guinea currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2015 it was Sao Tome and Principe ahead.
Papua New Guinea ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
Papua New Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.3% | 37.0% | 6.3% | Papua New Guinea |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Papua New Guinea or Sao Tome and Principe?
- Papua New Guinea, at 100.0% against 100.0% in Sao Tome and Principe as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Papua New Guinea and Sao Tome and Principe?
- 0.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Sao Tome and Principe?
- 5 years are reported by both, from 2015 to 2024.
- How do Papua New Guinea and Sao Tome and Principe rank globally for previously treated cases tested for rr-/mdr-tb?
- Papua New Guinea ranks 1st and Sao Tome and Principe ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.